Publication:
World’s First Experience of the Low-Dose Radionuclide Inhalation Therapy in the Treatment of COVID-19-Associated Viral Pneumonia: Phase 1/2 Clinical Trial

Простая страница элемента
dc.contributor.authorShegay, P.
dc.contributor.authorLeontyev, A.
dc.contributor.authorBaranovskii, D.
dc.contributor.authorDavydov, G.
dc.contributor.authorKlabukov, I. D.
dc.date.accessioned2024-12-28T11:48:26Z
dc.date.available2024-12-28T11:48:26Z
dc.date.issued2023
dc.format.extentС. 243-252
dc.identifier.citationWorld’s First Experience of the Low-Dose Radionuclide Inhalation Therapy in the Treatment of COVID-19-Associated Viral Pneumonia: Phase 1/2 Clinical Trial / Shegay, P. [et al.] // Current Radiopharmaceuticals. - 2023. - 16. - № 3. - P. 243-252. - 10.2174/1874471016666230307113045
dc.identifier.doi10.2174/1874471016666230307113045
dc.identifier.urihttps://www.doi.org/10.2174/1874471016666230307113045
dc.identifier.urihttps://www.scopus.com/record/display.uri?eid=2-s2.0-85162622124&origin=resultslist
dc.identifier.urihttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS_CPL&DestLinkType=FullRecord&UT=WOS:001026812400007
dc.identifier.urihttps://openrepository.mephi.ru/handle/123456789/30238
dc.relation.ispartofCurrent Radiopharmaceuticals
dc.titleWorld’s First Experience of the Low-Dose Radionuclide Inhalation Therapy in the Treatment of COVID-19-Associated Viral Pneumonia: Phase 1/2 Clinical Trial
dc.typeArticle
dspace.entity.typePublication
oaire.citation.issue3
oaire.citation.volume16
relation.isOrgUnitOfPublication4b108cd7-08a1-4350-ab3f-20450dec091d
relation.isOrgUnitOfPublication.latestForDiscovery4b108cd7-08a1-4350-ab3f-20450dec091d
Файлы
Коллекции
Публикации